Cyclopharm reports record half-year revenue on 74% U.S. growth
Cyclopharm said half-year revenue hit a record, driven by 74% U.S. growth and improved gross margins. Company also named Technegas as the preferred agent in new international guidelines.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.